Analysis of Cost Effectiveness of KRAS / BRAF Mutation Tests in Metastatic Colon Cancer Treatment


Sülkü S. N., Aydin Son Y., Işil Ülman F. Y.

AB Destekli Diğer Projeler, 2021 - 2021

  • Proje Türü: AB Destekli Diğer Projeler
  • Başlama Tarihi: Ocak 2021
  • Bitiş Tarihi: Mayıs 2021

Proje Özeti

ERA PerMed JTC2021

Analysis of Cost Effectiveness of KRAS / BRAF Mutation Tests in Metastatic Colon Cancer Treatment

Key Words:

Biomarker, KRAS/BRAF, Colorectal Cancer, Cost-Effectiveness, Machine Learning, Health Econometrics, Artificial Intelligence